Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn's disease with refractory septic shock after intestinal perforation: A case report

被引:1
|
作者
Notaro S. [1 ]
Sorrentino M. [2 ]
Ruocco A. [3 ]
Notaro A. [1 ]
Corcione A. [1 ]
Murino P. [1 ]
Piscitelli E. [1 ]
Tamborino M. [1 ]
机构
[1] Intensive Care Unit, AORN Dei Colli Vincenzo Monaldi Hospital, Naples
[2] Intensive Care Unit, Fatebenefratelli Hospital, Naples
[3] Department of Pharmacology, Federico II University of Naples, Naples
关键词
Corticosteroid; Refractory septic shock; Vasopressin;
D O I
10.1186/s13256-017-1456-3
中图分类号
学科分类号
摘要
Background: In this article, we present a clinical case of refractory septic shock resulting from intestinal perforation treated with high doses of vasopressin and hydrocortisone during emergency surgery. The use of such high doses of vasopressin for this type of shock is not described in the literature. Case presentation: A 49-year-old white woman with grade III obesity, Crohn's disease, and an intestinal perforation presented with refractory septic shock. Initially, a low dose of vasopressin was used. Then, the dosage was increased to 0.4 U/minute; in the literature, this is defined as "salvage therapy." This therapy consists of an initial load followed by a continuous infusion of hydrocortisone. Conclusions: The significant increase in her cardiac index and stroke volume index resulted in an improvement in peripheral resistance, gas exchange, and urine output and a decrease in her heart rate, interleukin-6 level, and tumor necrosis factor-α level. The administration of high doses of vasopressin and corticosteroids was demonstrated to be safe for the immune system, to reduce the systemic inflammatory response, and to have direct cardiovascular effects. Further studies are required to examine the use of vasopressin as an initial vasopressor as well as its use in high dosages and in combination with corticosteroids. © 2017 The Author(s).
引用
收藏
相关论文
共 45 条
  • [41] Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review
    Shin Kashima
    Kentaro Moriichi
    Katsuyoshi Ando
    Nobuhiro Ueno
    Hiroki Tanabe
    Sayaka Yuzawa
    Mikihiro Fujiya
    BMC Gastroenterology, 21
  • [42] Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review
    Kashima, Shin
    Moriichi, Kentaro
    Ando, Katsuyoshi
    Ueno, Nobuhiro
    Tanabe, Hiroki
    Yuzawa, Sayaka
    Fujiya, Mikihiro
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [43] Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
    Smeets, Fabienne G. M.
    Liedorp, Paulien R.
    van der Poel, Marjolein
    Miclea, Razvan L.
    Masclee, Ad A. M.
    Pierik, Marieke
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (11): : 1470 - 1473
  • [44] Dietetic advocacy for long-term use of exclusive enteral nutrition resulted in high-risk surgical avoidance for complicated fibrotic Crohn's disease- A case report
    Purcell, Liz
    McIvor, Carolyn
    Palmer, Michelle
    CLINICAL NUTRITION ESPEN, 2023, 57 : 1 - 4
  • [45] Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt's lymphoma with TP53 mutations
    Zhang, Qi
    Zhu, Xiaojian
    Liu, Bo
    Zhang, Yicheng
    Xiao, Yi
    FRONTIERS IN IMMUNOLOGY, 2023, 14